KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 134 filers reported holding KURA ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 8.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $129,779 | -17.8% | 14,900 | 0.0% | 0.03% | -22.9% |
| Q2 2023 | $157,940 | -14.6% | 14,900 | 0.0% | 0.04% | -50.0% |
| Q4 2022 | $184,909 | -4.7% | 14,900 | 0.0% | 0.07% | +45.8% |
| Q3 2022 | $194,000 | -29.7% | 14,900 | 0.0% | 0.05% | -20.0% |
| Q2 2022 | $276,000 | +15.0% | 14,900 | 0.0% | 0.06% | +27.7% |
| Q1 2022 | $240,000 | +11.6% | 14,900 | 0.0% | 0.05% | +27.0% |
| Q4 2021 | $215,000 | -24.8% | 14,900 | 0.0% | 0.04% | -28.8% |
| Q3 2021 | $286,000 | -4.0% | 14,900 | 0.0% | 0.05% | -10.3% |
| Q2 2021 | $298,000 | -29.2% | 14,900 | 0.0% | 0.06% | -34.8% |
| Q1 2021 | $421,000 | -16.6% | 14,900 | 0.0% | 0.09% | -22.6% |
| Q4 2020 | $505,000 | -1.0% | 14,900 | 0.0% | 0.12% | -17.3% |
| Q3 2020 | $510,000 | – | 14,900 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,849,947 | $16,871,517 | 9.37% |
| Prosight Management, LP | 1,932,456 | $17,623,999 | 5.58% |
| ACUTA CAPITAL PARTNERS, LLC | 702,093 | $6,403,088 | 4.29% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 350,445 | $3,196,058 | 3.93% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,335,845 | $66,902,906 | 3.62% |
| Affinity Asset Advisors, LLC | 856,535 | $7,811,599 | 2.20% |
| TCG Crossover Management, LLC | 1,423,642 | $12,983,615 | 1.91% |
| EcoR1 Capital, LLC | 5,806,871 | $52,958,664 | 1.79% |
| BVF INC/IL | 6,730,983 | $61,386,565 | 1.66% |
| DAFNA Capital Management LLC | 550,784 | $5,023,150 | 1.56% |